RIL
NVCR icon

Rothschild Investment LLC’s NovoCure NVCR Stock Holding History

Rothschild Investment LLC’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09K Sell
192
-30
-14% -$375 ﹤0.01% 2542
2025
Q4 		$2.87K Buy
222
+107
+93% +$1.37K ﹤0.01% 2184
2025
Q3 		$1.49K Sell
115
-55
-32% -$735 ﹤0.01% 2401
2025
Q2 		$3.03K Sell
170
-20
-11% -$349 ﹤0.01% 1783
2025
Q1 		$3.39K Buy
190
+70
+58% +$1.59K ﹤0.01% 1620
2024
Q4 		$3.58K Buy
120
+25
+26% +$529 ﹤0.01% 1479
2024
Q3 		$1.49K Buy
95
+85
+850% +$1.54K ﹤0.01% 1890
2024
Q2 		$171 Buy
+10
New +$176 ﹤0.01% 2538

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Rothschild Investment LLC's NVCR Position: Q1 2026 in Review

Rothschild Investment LLC reduced its NovoCure (NVCR) stake by 14% in Q1 2026, selling an estimated $375 and leaving 192 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2542.

Rothschild Investment LLC first reported a position in NVCR in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.58K in Q4 2024. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Rothschild Investment LLC held 192 shares of NovoCure worth $2.09K as of Q1 2026.
  • Rothschild Investment LLC sold 30 NovoCure shares in Q1 2026, an estimated $375.
  • NovoCure made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2542 holding.
  • Rothschild Investment LLC first reported a position in NovoCure in Q2 2024 and has held it in 8 quarters since.
  • Rothschild Investment LLC's NovoCure position peaked at $3.58K in Q4 2024.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.